{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:03:59Z","timestamp":1761491039982,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13721-020-00263-6","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:02:48Z","timestamp":1596844968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-167X","authenticated-orcid":false,"given":"Mostafa A.","family":"Hussien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-3521","authenticated-orcid":false,"given":"Ahmed E. M.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"key":"263_CR1","first-page":"5060","volume":"9","author":"MH Abdellattif","year":"2018","unstructured":"Abdellattif MH, Hussien MA, Alzahrani E (2018) New approaches of 4-aryl-2-hydrazinothiazole derivatives synthesis, molecular docking, and biological evaluations. Int J Pharm Sci Res 9:5060\u20135078","journal-title":"Int J Pharm Sci Res"},{"key":"263_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.molstruc.2019.06.092","volume":"1196","author":"MH Abdel-Rhman","year":"2019","unstructured":"Abdel-Rhman MH, Hussien MA, Mahmoud HM, Hosny NM (2019) Synthesis, characterization, molecular docking and cytotoxicity studies on N-benzyl-2-isonicotinoylhydrazine-1-carbothioamide and its metal complexes. J Mol Struct 1196:417\u2013428","journal-title":"J Mol Struct"},{"key":"263_CR3","doi-asserted-by":"publisher","first-page":"e5099","DOI":"10.1002\/aoc.5099","volume":"33","author":"I Althagafi","year":"2019","unstructured":"Althagafi I, El-Metwaly NM, Farghaly T (2019) Characterization of new Pt(IV)\u2014thiazole complexes: analytical, spectral, molecular modeling and molecular docking studies and applications in two opposing pathways. Appl Organomet Chem 33:e5099. https:\/\/doi.org\/10.1002\/aoc.5099","journal-title":"Appl Organomet Chem"},{"key":"263_CR4","doi-asserted-by":"publisher","first-page":"tay110","DOI":"10.1093\/jtm\/tay110","volume":"25","author":"JK Baird","year":"2018","unstructured":"Baird JK (2018) Tafenoquine for travelers\u2019 malaria: evidence, rationale and recommendations. J Travel Med 25:tay110. https:\/\/doi.org\/10.1093\/jtm\/tay110","journal-title":"J Travel Med"},{"key":"263_CR5","doi-asserted-by":"publisher","DOI":"10.2210\/pdb1q2w\/pdb","author":"JB Bonanno","year":"2003","unstructured":"Bonanno JB et al (2003) X-ray crystal structure of the SARS coronavirus main protease. Worldw Protein Data Bank. https:\/\/doi.org\/10.2210\/pdb1q2w\/pdb","journal-title":"Worldw Protein Data Bank"},{"key":"263_CR6","doi-asserted-by":"publisher","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","volume":"178","author":"L Caly","year":"2020","unstructured":"Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res 178:104787. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787","journal-title":"Antivir Res"},{"key":"263_CR7","doi-asserted-by":"publisher","DOI":"10.3410\/f.737494462.793573238","author":"C-M Chiang","year":"2020","unstructured":"Chiang C-M (2020) Faculty opinions recommendation of SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Fac Opin Ltd. https:\/\/doi.org\/10.3410\/f.737494462.793573238","journal-title":"Fac Opin Ltd"},{"key":"263_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","volume":"143","author":"G Chittick","year":"2017","unstructured":"Chittick G, Morrison M, Brundage T, Nichols WG (2017) Short-term clinical safety profile of brincidofovir: a favorable benefit\u2013risk proposition in the treatment of smallpox. Antivir Res 143:269\u2013277. https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.009","journal-title":"Antivir Res"},{"key":"263_CR9","unstructured":"Control CfD, Prevention (2014) Vaccine testing and the approval process. Webpage. Updated: May"},{"key":"263_CR10","doi-asserted-by":"publisher","first-page":"e0162199","DOI":"10.1371\/journal.pone.0162199","volume":"11","author":"J Dunning","year":"2016","unstructured":"Dunning J et al (2016) Experimental treatment of Ebola virus disease with brincidofovir. PLOS ONE 11:e0162199. https:\/\/doi.org\/10.1371\/journal.pone.0162199","journal-title":"PLOS ONE"},{"key":"263_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","volume":"12","author":"DF Florescu","year":"2014","unstructured":"Florescu DF, Keck MA (2014) Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses. Expert Rev Anti-infect Ther 12:1171\u20131178","journal-title":"Expert Rev Anti-infect Ther"},{"key":"263_CR12","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s40265-018-0979-2","volume":"78","author":"JE Frampton","year":"2018","unstructured":"Frampton JE (2018) Tafenoquine: first global approval. Drugs 78:1517\u20131523. https:\/\/doi.org\/10.1007\/s40265-018-0979-2","journal-title":"Drugs"},{"key":"263_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"J Gao","year":"2020","unstructured":"Gao J, Tian Z, Yang X (2020) Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioSci Trends 14:72\u201373. https:\/\/doi.org\/10.5582\/bst.2020.01047","journal-title":"BioSci Trends"},{"key":"263_CR14","doi-asserted-by":"publisher","unstructured":"GSK files for approval of world\u2019s first malaria vaccine (2014) Pharm J. https:\/\/doi.org\/10.1211\/pj.2014.20065965","DOI":"10.1211\/pj.2014.20065965"},{"key":"263_CR15","doi-asserted-by":"crossref","unstructured":"Hoffmann M et al. (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"263_CR16","doi-asserted-by":"publisher","DOI":"10.1037\/e496242006-019","author":"CP Hoiberg","year":"1991","unstructured":"Hoiberg CP, Rapaka RS (1991) FDA regulatory requirements for investigational new drugs and new drug applications: an update. Am Psychol Assoc (APA). https:\/\/doi.org\/10.1037\/e496242006-019","journal-title":"Am Psychol Assoc (APA)"},{"key":"263_CR32","doi-asserted-by":"publisher","unstructured":"Ketan ZA,  Naser AW, AL-Shmgani HS (2020) Synthesis, design, docking and biological activity of new benzo hydrazide derivatives (2020) Int J Pharm Res. https:\/\/doi.org\/10.31838\/ijpr\/2020.12.03.070","DOI":"10.31838\/ijpr\/2020.12.03.070"},{"key":"263_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935\u2013949. https:\/\/doi.org\/10.1038\/nrd1549","journal-title":"Nat Rev Drug Discov"},{"key":"263_CR18","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/v2122740","volume":"2","author":"R Lanier","year":"2010","unstructured":"Lanier R et al (2010) Development of CMX001 for the treatment of poxvirus infections. Viruses 2:2740\u20132762. https:\/\/doi.org\/10.3390\/v2122740","journal-title":"Viruses"},{"key":"263_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/s0959-440x(96)80061-3","volume":"6","author":"T Lengauer","year":"1996","unstructured":"Lengauer T, Rarey M (1996) Computational methods for biomolecular docking. Curr Opin Struct Biol 6:402\u2013406. https:\/\/doi.org\/10.1016\/s0959-440x(96)80061-3","journal-title":"Curr Opin Struct Biol"},{"key":"263_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.poly.2018.10.062","volume":"158","author":"KH Mashat","year":"2019","unstructured":"Mashat KH, Babgi BA, Hussien MA, Arshad MN, Abdellattif MH (2019) Synthesis, structures, DNA-binding and anticancer activities of some copper (I)-phosphine complexes. Polyhedron 158:164\u2013172","journal-title":"Polyhedron"},{"key":"263_CR21","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3201\/eid1911.131172","volume":"19","author":"ZA Memish","year":"2013","unstructured":"Memish ZA et al (2013) Middle East respiratory syndrome coronavirus in bats. Saudi Arabia Emerg Infect Dis 19:1819. https:\/\/doi.org\/10.3201\/eid1911.131172","journal-title":"Saudi Arabia Emerg Infect Dis"},{"key":"263_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s13721-020-00231-0","author":"S Mubarak","year":"2020","unstructured":"Mubarak S, Khanday MA, Lone AUH (2020) Mathematical analysis based on eigenvalue approach to study liver metastasis disease with applied drug therapy. Netw Model Anal Health Inf Bioinf. https:\/\/doi.org\/10.1007\/s13721-020-00231-0","journal-title":"Netw Model Anal Health Inf Bioinf"},{"key":"263_CR23","doi-asserted-by":"publisher","DOI":"10.1142\/s1793524520500382","author":"PA Naik","year":"2020","unstructured":"Naik PA (2020) Modeling the mechanics of calcium regulation in T lymphocyte: a finite element method approach. Int J Biomath. https:\/\/doi.org\/10.1142\/s1793524520500382","journal-title":"Int J Biomath"},{"key":"263_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s13721-017-0158-5","author":"PA Naik","year":"2017","unstructured":"Naik PA, Pardasani KR (2017) Three-dimensional finite element model to study calcium distribution in oocytes. Netw Model Anal Health Inf Bioinf. https:\/\/doi.org\/10.1007\/s13721-017-0158-5","journal-title":"Netw Model Anal Health Inf Bioinf"},{"key":"263_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s13721-018-0172-2","author":"PA Naik","year":"2018","unstructured":"Naik PA, Pardasani KR (2018) 2D finite-element analysis of calcium distribution in oocytes. Netw Model Anal Health Inf Bioinf. https:\/\/doi.org\/10.1007\/s13721-018-0172-2","journal-title":"Netw Model Anal Health Inf Bioinf"},{"key":"263_CR26","doi-asserted-by":"publisher","first-page":"2050013","DOI":"10.1142\/s0219720020500134","volume":"18","author":"PA Naik","year":"2020","unstructured":"Naik PA, Zu J (2020) Modeling and simulation of spatial-temporal calcium distribution in T lymphocyte cell by using a reaction-diffusion equation. J Bioinf Comput Biol 18:2050013. https:\/\/doi.org\/10.1142\/s0219720020500134","journal-title":"J Bioinf Comput Biol"},{"key":"263_CR27","unstructured":"Organization WH Ebola virus disease. Fact sheet N 103. Updated September 2014. Fecha de consulta: 18 de octubre de 2014"},{"key":"263_CR28","doi-asserted-by":"publisher","first-page":"A61","DOI":"10.1016\/j.antiviral.2008.01.132","volume":"78","author":"S Parker","year":"2008","unstructured":"Parker S, Oberle C, Touchette E, Buller RM (2008a) Efficacy of therapeutic intervention with an oral ether lipid analogue of cidofovir (CMX001) in a lethal mousepox model. Antivir Res 78:A61\u2013A62. https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.132","journal-title":"Antivir Res"},{"key":"263_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","volume":"77","author":"S Parker","year":"2008","unstructured":"Parker S et al (2008b) Efficacy of therapeutic intervention with an oral ether\u2013lipid analogue of cidofovir (CMX001) in a lethal mousepox model. Antiviral Res 77:39\u201349","journal-title":"Antiviral Res"},{"key":"263_CR37","unstructured":"Schepers J. Chimerix announces emergency investigational new drug applications for brincidofovir authorized by FDA for patients with Ebola virus disease"},{"key":"263_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0974-777X.176140","volume":"8","author":"V Sikka","year":"2016","unstructured":"Sikka V et al (2016) The emergence of Zika virus as a global health security threat: a review and a consensus statement of the INDUSEM Joint Working Group (JWG). J Global Infect Dis 8:3","journal-title":"J Global Infect Dis"},{"key":"263_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"S Su","year":"2016","unstructured":"Su S et al (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24:490\u2013502. https:\/\/doi.org\/10.1016\/j.tim.2016.03.003","journal-title":"Trends Microbiol"},{"key":"263_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00127-20","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. https:\/\/doi.org\/10.1128\/jvi.00127-20","journal-title":"J Virol"},{"key":"263_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C et al (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B 10:766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"263_CR36","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-16858\/v2","volume-title":"Spatial statistics and influencing factors of the novel coronavirus pneumonia 2019 epidemic in Hubei Province","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Wang Y, Chen F, Zhu M (2020) Spatial statistics and influencing factors of the novel coronavirus pneumonia 2019 epidemic in Hubei Province. Res Square, China. https:\/\/doi.org\/10.21203\/rs.3.rs-16858\/v2"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-020-00263-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-020-00263-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-020-00263-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T23:08:45Z","timestamp":1628377725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-020-00263-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1007\/s13721-020-00263-6","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"type":"print","value":"2192-6662"},{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"56"}}